Retractable Technologies, Inc. (RVP) Short Interest Update

Retractable Technologies, Inc. (NYSEAMERICAN:RVP) was the target of a significant decrease in short interest in the month of January. As of January 12th, there was short interest totalling 28,603 shares, a decrease of 68.6% from the December 29th total of 90,950 shares. Currently, 0.3% of the company’s stock are sold short. Based on an average trading volume of 490,944 shares, the days-to-cover ratio is currently 0.1 days.

Shares of Retractable Technologies (NYSEAMERICAN:RVP) opened at $0.73 on Tuesday. Retractable Technologies has a 12-month low of $0.54 and a 12-month high of $1.48. The firm has a market capitalization of $23.93, a price-to-earnings ratio of -4.24 and a beta of 0.41.

Retractable Technologies (NYSEAMERICAN:RVP) last posted its quarterly earnings data on Tuesday, November 14th. The company reported ($0.01) earnings per share for the quarter. The company had revenue of $10.41 million for the quarter. Retractable Technologies had a negative return on equity of 3.58% and a negative net margin of 0.64%.

Separately, ValuEngine raised Retractable Technologies from a “sell” rating to a “hold” rating in a research report on Monday, October 2nd.

ILLEGAL ACTIVITY WARNING: This story was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this story on another publication, it was illegally stolen and reposted in violation of US & international copyright legislation. The correct version of this story can be read at https://www.dispatchtribunal.com/2018/01/30/retractable-technologies-inc-rvp-short-interest-update.html.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops and manufactures safety medical products for the healthcare industry. The Company markets VanishPoint and PatientSafe products. The VanishPoint products are designed specifically to prevent needle stick injuries and to prevent reuse. The VanishPoint safety products include tuberculin, insulin and allergy antigen VanishPoint syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL and 10mL VanishPoint syringes, and the VanishPoint autodisable syringe.

Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply